Type
Internal restructuring
Country
Ireland
Region
Southern and Eastern; South-West (IRL);
Location of affected unit(s)
Cork
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

90 jobs
Number of planned job losses
Job loss
Announcement Date
2 October 2012
Employment effect (start)
Foreseen end date
30 April 2013

Description

Merck Sharp and Dohme (MSD), which produces pharmaceutical products for the global healthcare industry, has announced 90 redundancies at its Cork plant in Ireland. The job losses are expected to occur over the next six months. The company said the redundancies are required due to declining demand for products from the plant.

MSD employs 2,300 staff across Ireland in Carlow, Cork, Dublin, Tipperary and Wicklow and manufactures prescription medicines, vaccines, biologic therapies, consumer care and animal health products. The Cork plant opened in 1980 and employs 455 staff.


Sources

  • 3 October 2012: The Irish Independent

Citation

Eurofound (2012), Merck Sharp and Dohme, Internal restructuring in Ireland, factsheet number 74268, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/74268.